One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1093/annonc/mdx370.024
Copy DOI
Export
Save
Share
Cite Journal: Annals of Oncology |  Publication Date: Sep 1, 2017 |
 Citations: 3 |  License type: elsevier-specific: oa user license |
Affiliation: Dana-Farber Cancer Institute, The Christie NHS Foundation Trust, Carlo Forlanini Hospital, Nottingham University Hospitals NHS Trust, Ziekenhuisnetwerk Antwerpen Stuivenberg, 21st Century Oncology (United States), Roswell Park Cancer Institute, Ospedale San Luigi Gonzaga, Hospital San Pedro de Alcántara, Dietrich Bonhoeffer Klinikum, Urology Associates, Medical School Berlin, Tulane University, Cliniques Universitaires Saint-Luc
807P - First interim results of the radium-223 (Ra-223) REASSURE observational study: Analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza)
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
